Cite
HARVARD Citation
Lightner, A. et al. (n.d.). P407 A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: An interim analysis. Journal of Crohn's and colitis. pp. i398-i399. [Online].